Top Markets
Coin of the day
Vectus Biosystems Limited Vectus Biosystems Limited

Vectus Biosystems Limited

VBS
Ранг среди акций #33546
Vectus Biosystems Limited, an Australian medical research and development firm,... Vectus Biosystems Limited, an Australian medical research and development firm, specializes in devising therapies for fibrotic conditions and hypertension. Its pharmaceutical pipeline addresses ailments affecting the heart, kidneys, liver, and lungs. The company's leading experimental drug, VB0004, aims to counter the degradation of functional tissue resulting from fibrosis, scarring, and elevated blood pressure. Furthermore, Vectus intends to advance treatments for hepatic fibrotic diseases, such as non-alcoholic steatohepatitis, and various pulmonary fibrotic disorders. Beyond its therapeutic endeavors, the company also provides AccuCal and RealCount software, tools engineered to enhance the swiftness and precision of DNA and RNA quantification in laboratory settings. Established in 2005, Vectus Biosystems is headquartered in Rosebery, Australia.
Цена акции
$0.11989842
Рыночная капитализация
$7.42M
Изменение (1 день)
6.25%
Изменение (1 год)
179.27%
Страна
AU
Торговля Vectus Biosystems Limited (VBS)

Категория

Коэффициент P/B для Vectus Biosystems Limited (VBS)
Коэффициент P/B на 2026 TTM: 0
Согласно последним финансовым отчетам и цене акций Vectus Biosystems Limited, текущий коэффициент P/B (TTM) составляет 0. В конце 2026 он составлял 0.
История P/B для Vectus Biosystems Limited с 2026 по 2026
Коэффициент P/B в конце каждого года
Год P/B Изменить
Недостаточно данных для указанных дат.
Коэффициент P/B для аналогичных компаний или конкурентов
Компания P/B Разница P/B Страна
6.3419 -
US
6.2413 -
NL
- -
CH
- -
KR
3.4612 -
BE